108 related articles for article (PubMed ID: 718735)
1. The effect of clofibrate and pyridinol carbamate on the circulating immune complexes and cellular immune response in experimental atherosclerosis.
Szondy E; Horváth M; Füst G; Link E; Fehér J; Gerö S
Atherosclerosis; 1978 Nov; 31(3):251-7. PubMed ID: 718735
[TBL] [Abstract][Full Text] [Related]
2. [The effect of clofibrate (Miscleron) and pyridinol carbamate (Prodectin) on immunologic factors in experimental arteriosclerosis].
Szondy E; Horváth M; Füst G; Fehér J; Link E; Gerö S
Orv Hetil; 1979 Jun; 120(23):1391-2. PubMed ID: 492681
[No Abstract] [Full Text] [Related]
3. Long term lathyrism and atherogenic diet in the rat. Protective action of pyridinol carbamate.
Pieraggi MT; De Graeve J; Julian M; Thiers JC; Bouissou H
Virchows Arch A Pathol Anat Histol; 1980; 387(1):59-66. PubMed ID: 7467116
[TBL] [Abstract][Full Text] [Related]
4. [The effect of ximedon on cholesterol metabolism and experimental atherosclerosis in rabbits].
Dautova GS; Kosykh VA; Repin VS; Kamburg RA; Ibragimov OB; Popova LG; Valeeva IKh
Eksp Klin Farmakol; 1995; 58(1):25-9. PubMed ID: 7787689
[TBL] [Abstract][Full Text] [Related]
5. Aortic lathyrism: ultrastructural study of lesions in the aortic wall and the protective effect of pyridinol carbamate.
Pieraggi MT; Julian M; Bouissou H
Gerontologia; 1974; 20(4):193-211. PubMed ID: 4463145
[No Abstract] [Full Text] [Related]
6. Chronic lathyrism and pyridinol carbamate. Study of aorta and plasma during long term intoxication.
Julian M; De Graeve J; Pieraggi MT; Thiers JC; Bouissou H
Pharmacol Res Commun; 1980 Oct; 12(9):847-54. PubMed ID: 7443765
[No Abstract] [Full Text] [Related]
7. Investigation by immunofluorescence of arterial lesions in rabbits on two different lipid supplements and treated with pyridinol carbamate.
Walton KW; Dunkerley DJ; Johnson AG; Khan MK; Morris C; Watts RB
Atherosclerosis; 1976; 23(1):117-39. PubMed ID: 802937
[TBL] [Abstract][Full Text] [Related]
8. N-mononitrosopyridinol carbamate: the principal mutagen formed by nitrosation of pyridinol carbamate.
Kanaya H; Takeda Y
Cancer Lett; 1983 Mar; 18(2):143-8. PubMed ID: 6339034
[No Abstract] [Full Text] [Related]
9. Pyridinolcarbamate and experimental atherosclerosis. Correlation of hypocholesterolemic and antiatherogenic effects.
Albert EN; Kassira WN; Muesing R; Vahouny GV
Atherosclerosis; 1978 Oct; 31(2):205-15. PubMed ID: 728238
[TBL] [Abstract][Full Text] [Related]
10. [Use of clofibrate and pyridinol carbamate singly or in combination in the antiarteriosclerotic therapy].
Meciani L; Boeri S; Ricci G
Minerva Cardioangiol; 1974; 22(7-8):512-42. PubMed ID: 4606052
[No Abstract] [Full Text] [Related]
11. The effect of Etofibrate (Lipo-Merz) on "in vitro" cellular immune response and on lipid parameters of men with myocardial infarction and with arteriosclerosis obliterans.
Horváth M; Varsányl M; Jovanovich N; Romics L; Gerö S
Allergol Immunopathol (Madr); 1990; 18(2):95-9. PubMed ID: 2371944
[TBL] [Abstract][Full Text] [Related]
12. [Effect of pyridinol carbamate on long-term lathyrism and experimental atheroma in the rat. Histological and biochemical study].
Bouissou H; de Graeve J; Julian M; Pieraggi MT; Thiers JC
Paroi Arterielle; 1980; 6(1):3-15. PubMed ID: 7422355
[TBL] [Abstract][Full Text] [Related]
13. [Critical study of the in vitro and in vivo effect of pyridinol carbamate on platelet adhesiveness and aggregation].
Prost-Djovakovic RJ; Lecrubier C; Doumenc J; Samama M
Therapie; 1975; 30(3):429-42. PubMed ID: 772874
[No Abstract] [Full Text] [Related]
14. Absence of an effect of tolerance to milk protein on experimental atherosclerosis in rabbits.
Notley JR; Gibney MJ; Gallagher PJ
Atherosclerosis; 1984 Aug; 52(2):199-202. PubMed ID: 6477672
[TBL] [Abstract][Full Text] [Related]
15. Mutagenicity of N-nitroso pyridinol carbamate with the Salmonella/mammalian microsome test.
Börzönyi B; Ferencz A; Surján A; Pintér A; Nádasdi I; Roller PP; Török G; Kiss K
Cancer Lett; 1979 Jul; 7(2-3):135-9. PubMed ID: 476608
[TBL] [Abstract][Full Text] [Related]
16. Biochemical criteria for the evaluation of drug efficiency on adjuvant arthritis and nephrotoxic serum nephritis in the rat: studies with phenylbutazone, L-Asparaginase, colchicine, lysine acetylsalicylate, and pyridinol carbamate.
Sternberg M; Peyroux J; Grochulski A; Engler R; Feret J; Moisy M; Lagrue G; Jayle MF
Can J Physiol Pharmacol; 1975 Jun; 53(3):368-74. PubMed ID: 1148923
[TBL] [Abstract][Full Text] [Related]
17. [Hypolipemic action of various drugs in rats poisoned with Triton WR 1339].
Cepeda L; Gómez MP; Alsasua MT
Rev Esp Fisiol; 1982; 38 Suppl():335-7. PubMed ID: 7146589
[TBL] [Abstract][Full Text] [Related]
18. Effect of miscleron on serum lipid parameters in atherosclerosis induced by cholesterol.
Virág S; Dénes R; Pozsonyi T; Tury K
Ther Hung; 1971; 19(4):148-9. PubMed ID: 4336261
[No Abstract] [Full Text] [Related]
19. The effect of niceritrol (pentaerythritoltetranicotinate) and clofibrate upon hyperlipemia and atherosclerosis induced in rabbits by cholesterol-free semisynthetic diets.
Brattsand R
Atherosclerosis; 1974; 20(3):453-67. PubMed ID: 4373017
[No Abstract] [Full Text] [Related]
20. [Pharmacotherapy of peripheral arteriosclerosis].
Belousov IuB; Savenkov PM; Sidel'man AA; Parfenov AS; Savenkov MP
Kardiologiia; 1978 Aug; 18(8):36-43. PubMed ID: 99596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
